Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 0.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.27 | 2.26 |
NAV | ₹10.51 | ₹147.97 |
Fund Started | 25 Sep 2023 | 13 Oct 2005 |
Fund Size | ₹795.48 Cr | ₹1385.43 Cr |
Exit Load | Exit load of 1%, if redeemed within 12 months. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -0.25% | 12.35% |
3 Year | - | 18.03% |
5 Year | - | 20.20% |
1 Year
3 Year
5 Year
Equity | 95.55% | 94.94% |
Cash | 3.79% | 3.99% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
PB Fintech Ltd. | 7.51% |
Info Edge (India) Ltd. | 7.16% |
Zomato Ltd. | 7.02% |
FSN E-Commerce Ventures Ltd. | 5.30% |
KPIT Technologies Ltd. | 4.82% |
Affle (India) Ltd. | 4.82% |
Praj Industries Ltd. | 4.50% |
RateGain Travel Technologies Ltd. | 4.09% |
Awfis Space Solutions Ltd. | 3.99% |
Nazara Technologies Ltd. | 3.82% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.60% |
Axis Bank Ltd. | 6.91% |
Reliance Industries Ltd. | 5.65% |
Bharti Airtel Ltd. | 5.45% |
HDFC Bank Ltd. | 4.98% |
State Bank of India | 4.97% |
NTPC Ltd. | 4.55% |
Larsen & Toubro Ltd. | 4.01% |
Infosys Ltd. | 3.95% |
Sun Pharmaceutical Industries Ltd. | 3.17% |
Name | Nitin Jain | Sri Sharma |
Start Date | 01 Oct 2024 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to provide medium to long-term capital appreciation through investment primarily in growth and innovation-oriented equity and equity-related instruments. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 25 Sep 2023 | 13 Oct 2005 |
Description
Launch Date